Cardiovascular Physiology - WBUHS 1st Professional MBBS Exam Guide

• Group A - Long Answer Questions (LAQ): 12 marks each
• Group B - Short Answer Questions (SAQ): 7 marks each
• Group C - Short Notes: 4 marks each
• Group D - Explain Why / Application: 2-3 marks each

GROUP A - LONG ANSWER QUESTIONS (12 Marks)

1. Cardiac Cycle [Most Repeated - 2+6+4]

• All valves closed
• LV pressure rises rapidly from ~5 mmHg to 80 mmHg
• Volume remains constant at End Diastolic Volume (EDV) = ~130 mL
• Starts when LV pressure exceeds LA pressure (mitral valve closes)
• Ends when LV pressure exceeds aortic pressure (80 mmHg)

• Aortic valve opens
• LV pressure peaks at ~120 mmHg
• Volume falls from 130 mL to ~60 mL (Stroke Volume = 70 mL)
• T-wave of ECG occurs; aortic pressure peaks
• Divided into rapid ejection (first 1/3) and reduced ejection (last 2/3)

• All valves again closed
• LV pressure falls rapidly from 80 mmHg to ~5 mmHg
• Volume remains constant at End Systolic Volume (ESV) = ~60 mL

• Mitral valve opens when LV pressure falls below LA pressure
• Volume increases from 60 mL to 130 mL
• Three sub-phases: Rapid filling → Slow filling (Diastasis) → Atrial systole (contributes ~25 mL)

• LV pressure curve (rises during contraction, peaks ~120 mmHg)
• Aortic pressure curve (dicrotic notch marks aortic valve closure)
• LV volume curve (falls during ejection, lowest at ESV)
• ECG: P wave → Atrial systole; QRS → Ventricular systole; T wave → Repolarization
• Phonocardiogram: S1 (MV closure) and S2 (AV closure)

2. Regulation of Blood Pressure [Repeated - 8+2+2]

• Receptors: High-pressure baroreceptors in carotid sinus (CN IX) and aortic arch (CN X)
• Afferents: Hering's nerve → CN IX → NTS in medulla; Aortic depressor nerve → CN X → NTS
• Integration: Nucleus Tractus Solitarius (NTS) → Cardiovascular centre (vasomotor + cardioinhibitory)
• Response to raised BP: ↑ baroreceptor firing → ↓ sympathetic output + ↑ vagal tone → ↓ HR, ↓ contractility, vasodilation → BP falls
• Response to fall in BP: Opposite - ↑ sympathetic, ↓ vagal → ↑ HR, vasoconstriction → BP rises
• Operates within seconds; resets in chronic hypertension

• Peripheral chemoreceptors (carotid + aortic bodies): respond to ↓PO2, ↑PCO2, ↓pH → vasoconstriction + ↑BP
• Central chemoreceptors (medulla): respond to ↑PCO2 → vasomotor centre stimulated

• Triggered when cerebral blood flow falls severely
• Massive sympathetic discharge → severe hypertension + bradycardia
• Last-ditch mechanism; indicates brain herniation

• ↓BP/↓Na+ → Renin from JG cells → Angiotensin I → (ACE in lung) → Angiotensin II
• Ang II: potent vasoconstrictor + stimulates aldosterone → Na+/water retention → ↑BP

• ↓BP → ↓capillary hydrostatic pressure → fluid moves from interstitium into capillaries → ↑blood volume → ↑BP

• Most powerful long-term regulator
• ↑BP → pressure natriuresis/diuresis → ↓blood volume → BP returns to normal
• Operates over hours to days

• Regulate Na+ and water balance → long-term blood volume control

3. ECG - Waves, Segments and Heart Block [Repeated - 6+2+4]

• P wave absent: atrial fibrillation; tall + broad P: atrial enlargement
• Prolonged PR: 1st degree heart block
• Widened QRS: bundle branch block or ventricular arrhythmia
• ST elevation: myocardial infarction (injury current); ST depression: ischemia/digitalis
• Prolonged QT: risk of torsades de pointes (dangerous arrhythmia)
• Tall T: hyperkalemia; inverted T: ischemia, LBBB, ventricular hypertrophy

• PR interval >0.20 sec (>5 small squares)
• All P waves followed by QRS
• Benign; no treatment needed
• ECG: Prolonged PR interval

• Type I (Mobitz I / Wenckebach): Progressive PR lengthening until a P wave is not conducted (dropped QRS). Benign.
• Type II (Mobitz II): Constant PR interval but sudden non-conducted P waves. More serious - can progress to complete block. Needs pacemaker.

• No relationship between P waves and QRS complexes (AV dissociation)
• Atria and ventricles beat independently
• Escape rhythm: junctional (rate 40-60 bpm) or ventricular (rate 20-40 bpm)
• Symptoms: syncope (Stokes-Adams attacks), heart failure
• Requires permanent pacemaker

4. Cardiac Output [Repeated - 2+6+4]

• CO = Heart Rate × Stroke Volume
• Normal: 5 L/min (at rest, 70 kg male)
• Cardiac Index = CO / Body Surface Area = 3.2 L/min/m²

• Normal: 60-100 bpm (SA node sets the pace at ~70 bpm)
• ↑HR by: Sympathetic (beta-1), catecholamines, thyroid hormones, fever, exercise, ↓vagal tone
• ↓HR by: Parasympathetic (vagus), ↑ICP (Cushing reflex), athletes (vagal dominance)
• Note: Too fast HR (>180) is counterproductive as it reduces diastolic filling time → ↓SV → ↓CO

• = End-diastolic volume (EDV); the stretch on ventricular muscle before contraction
• Frank-Starling Law: "The strength of ventricular contraction is proportional to initial length of muscle fiber (within physiological limits)"
• ↑Venous return → ↑EDV → ↑stretch → ↑crossbridge formation → ↑SV
• Physiological importance: Ensures both ventricles eject equal stroke volumes; automatically compensates for increased venous return (exercise, lying down)
• Increased by: ↑venous return, bradycardia, ↑blood volume
• Decreased by: hemorrhage, dehydration, tachycardia

• = Resistance against which ventricle must eject blood = Aortic pressure (systemic vascular resistance)
• ↑Afterload → ↑wall tension needed → ↑O2 consumption → ↓SV (if not compensated)
• Increased in: hypertension, aortic stenosis
• Decreased by: vasodilator drugs

• = Intrinsic ability of heart to contract at a given preload and afterload
• ↑Contractility: Sympathetic stimulation, catecholamines, cardiac glycosides (digoxin), ↑Ca²+, Bowditch effect (↑HR)
• ↓Contractility: Heart failure, beta-blockers, calcium channel blockers, hypoxia, acidosis

• Determined by: mean systemic filling pressure - right atrial pressure
• Factors promoting venous return: skeletal muscle pump, respiratory pump (inspiration ↓intrathoracic pressure → ↑venous return), venous tone, body position

• Cause: During systole, high stroke volume (LV pumps normal + regurgitated blood) → very high systolic BP. During diastole, blood flows back into LV → aortic diastolic pressure falls very low.
• Result: Pulse pressure (systolic - diastolic) greatly increased (normal 40 mmHg; in AR can be 80-100 mmHg)
• Clinical signs: "Water hammer pulse" (Corrigan's pulse) - abrupt rise and rapid collapse; Pistol shot sound over femoral artery; Duroziez sign; head bobbing (de Musset's sign); capillary pulsations (Quincke's sign)

• Cause: During diastole, blood jets back from aorta through incompetent valve into LV, creating turbulent flow
• Character: High-pitched, blowing, early diastolic murmur at left sternal border (3rd-4th ICS); best heard leaning forward in expiration
• Austin Flint murmur: Functional mid-diastolic murmur at apex due to regurgitant jet partially closing mitral valve

GROUP B - SHORT ANSWER QUESTIONS (7 Marks)

1. Baroreceptor Reflex [2+5]

• Carotid sinus baroreceptors: Located at bifurcation of common carotid artery; innervated by CN IX (Hering's nerve); most sensitive, respond to pressures of 60-180 mmHg
• Aortic arch baroreceptors: Innervated by CN X (vagus); less sensitive, higher threshold

• These are mechanoreceptors (stretch receptors) in vessel walls
• Normal firing rate at MAP ~100 mmHg
• ↑BP → ↑wall stretch → ↑receptor firing → afferents to NTS in medulla → NTS activates cardioinhibitory centre (↑vagal tone) + inhibits vasomotor centre (↓sympathetic)
• Net effect: ↓HR + ↓contractility + vasodilation → CO falls → TPR falls → BP returns to normal

• ↓BP → ↓stretch → ↓receptor firing → ↓NTS activity → ↑sympathetic + ↓vagal → ↑HR + ↑contractility + vasoconstriction → BP rises

• Resets over 1-2 days in chronic hypertension (baroreceptors adapt to new level)
• Cannot maintain long-term BP control (renal mechanism is superior for long-term)

2. Marey's Law [2+4+1]

• ↑BP → ↑stretch on carotid sinus/aortic arch baroreceptors → ↑firing in CN IX/X → NTS in medulla → ↑vagal (cardioinhibitory) activity + ↓sympathetic → ↓HR
• Reverse: ↓BP → ↓baroreceptor firing → ↓vagal + ↑sympathetic → ↑HR

1. Bainbridge Reflex: ↑venous return → ↑right atrial stretch → ↑HR (despite ↑BP) - tachycardia with ↑BP
2. Cushing Reflex: ↑ICP → ↑BP + bradycardia (Marey's law here) but primary cause is ischemic CNS, not arterial baroreceptors
3. Exercise: ↑HR despite ↑BP (cortical override of baroreceptors)
4. Thyrotoxicosis / Fever: ↑HR regardless of BP
5. Emotional stress/anxiety: ↑HR despite ↑BP

3. Cardiac Output - Fick's Method [2+5]

1. Measure O₂ consumption: Patient breathes into a spirometer for 1 minute → O₂ consumed = ~250 mL/min at rest
2. Collect arterial blood: From any systemic artery (e.g., brachial artery) → measure O₂ content (~200 mL O₂/L blood)
3. Collect mixed venous blood: Via cardiac catheter from pulmonary artery (right heart) → O₂ content (~150 mL O₂/L blood)
4. Calculate: CO = 250 mL/min ÷ (200 - 150) mL/L = 250/50 = 5 L/min

GROUP C - SHORT NOTES (4 Marks Each)

1. Augmented Limb Leads in ECG

• aVR, aVL, aVF are unipolar leads derived from Goldberger's modification of Wilson's central terminal
• aVR = Right arm; views heart from right shoulder; normally all complexes negative (QRS mainly negative, T negative)
• aVL = Left arm; views heart from left shoulder
• aVF = Left foot; views inferior surface of heart (diaphragmatic surface)
• "Augmented" because signal is amplified by 50% by disconnecting the limb being recorded from the central terminal
• Clinical uses: aVF shows inferior MI (with II, III); aVL shows lateral MI; aVR - ST elevation suggests left main/proximal LAD disease

2. CVS Adjustments During Exercise

• ↑HR (up to 180-200 bpm) - sympathetic + withdrawal of vagal tone + circulating catecholamines
• ↑Contractility (↑SV up to 110 mL from 70 mL)
• ↑CO (up to 20-25 L/min; trained athletes may reach 35 L/min)

• ↑Blood flow to working muscles (arterioles dilate due to local metabolites: CO₂, lactic acid, adenosine, ↓pH, ↓O₂)
• ↑Coronary blood flow (up to 5x resting)
• ↓Flow to gut, kidneys, skin (initially)
• ↑Skin blood flow later (thermoregulation)

3. Standard Limb Leads in ECG

• Bipolar leads (I, II, III) based on Einthoven's triangle
• Lead I: Left arm (+) - Right arm (-); records lateral heart activity
• Lead II: Left leg (+) - Right arm (-); greatest voltage normally (R wave tallest); detects inferior MI
• Lead III: Left leg (+) - Left arm (-); inferior heart
• Einthoven's Law: Voltage in Lead II = Lead I + Lead III
• Standard recording: Paper speed 25 mm/sec; 1 mV = 10 mm; each small square = 0.04 sec; large square = 0.20 sec

4. PR Interval

• Measured from beginning of P wave to beginning of QRS complex
• Normal: 0.12-0.20 seconds (3-5 small squares)
• Represents: Atrial depolarization + AV nodal delay (AV node slows conduction to allow atrial contraction before ventricular systole)
• Short PR (<0.12 sec): Pre-excitation syndromes (WPW syndrome - accessory pathway bypasses AV node); LGL syndrome; junctional rhythms
• Long PR (>0.20 sec): 1st degree AV block (seen in rheumatic fever, digoxin toxicity, myocarditis, elderly)
• AV node delay is normally 0.07-0.10 sec; acts as a "gatekeeper"

5. 2nd Degree AV Nodal Block

• Progressive PR interval lengthening with each beat until one P wave fails to conduct (dropped QRS)
• Then cycle repeats (grouped beating)
• Site: AV node (supranodal)
• Cause: Inferior MI, increased vagal tone, digoxin toxicity
• Usually benign; may not need pacemaker

• Constant PR interval but sudden, unexpected dropped QRS (non-conducted P wave)
• Site: Below AV node (His-Purkinje); more dangerous
• Cause: Anterior MI, fibrosis, cardiomyopathy
• May progress to complete heart block → requires permanent pacemaker

6. Subendocardial Region of LV is Specially Vulnerable to Ischemia

1. Highest wall tension: Subendocardial region experiences maximum compressive force during systole (Laplace's law: T = P × r/2h); this compresses intramyocardial vessels
2. Perfusion only during diastole: Coronary perfusion of LV occurs mainly in diastole; LV subendocardium is compressed during systole. If diastolic time shortens (tachycardia) or diastolic aortic pressure falls, subendocardium is underperfused
3. Longest distance from epicardial coronary arteries: Blood must travel from epicardial vessels through the wall to reach subendocardium - highest resistance path
4. Higher oxygen demand: Innermost fibers do more work due to greater shortening needed
5. End-artery territory: No anastomotic protection

7. Normal ECG Waves (Brief)

• P, QRS, T wave significance
• Normal values
• Represent sequential depolarization and repolarization
• U wave: Purkinje/papillary muscle repolarization

8. Sinoaortic Reflex

• Another name for the baroreceptor reflex (see Group B Q1 above, in 4-mark condensed form)
• "Sino" = carotid sinus; "Aortic" = aortic arch
• Rapid neural reflex maintaining BP homeostasis via stretch receptors in carotid sinus and aortic arch

GROUP D - EXPLAIN WHY (2-3 Marks Each)

1. Why does tachycardia occur in cardiovascular shock?

• Shock → ↓BP → ↓baroreceptor firing → reflex ↑sympathetic + ↓vagal → ↑HR (tachycardia); attempts to maintain CO

1. Why does inspiration cause physiological splitting of S2?

• Inspiration → ↓intrathoracic pressure → ↑venous return to right heart → ↑RV stroke volume → pulmonary valve closes later (P2 delayed); simultaneously, ↑pulmonary vascular capacitance → ↓venous return to LV → ↓LV stroke volume → aortic valve closes earlier (A2 earlier) → A2-P2 gap widens → audible split

1. Why is aortic valve closed at rest longer than open?

• Diastole (0.5 sec) > systole (0.3 sec) at normal heart rate; valve open only during ejection phase

1. Why does lying down increase cardiac output?

• ↑venous return (gravity assists pooled blood in legs to return to heart) → Frank-Starling mechanism → ↑SV → ↑CO

1. Why does the left ventricle have a thicker wall than the right?

• LV pumps against systemic circulation (pressure ~120/80 mmHg); RV against pulmonary circulation (~25/10 mmHg); LV wall is 3x thicker (8-12 mm vs 3-5 mm)

QUICK SUMMARY: HIGH-FREQUENCY TOPICS BY YEAR

Exam tip: WBUHS Paper 1 physiology always has one long question from CVS. The cardiac cycle, BP regulation, and ECG rotate as the most common 12-mark questions. Learn your Wiggers diagram, ECG intervals, and the baroreceptor arc diagram - they appear in virtually every exam.

Pancreatic Juice - Composition, Functions, Control of Secretion & Exocrine Function Tests

I. INTRODUCTION

• Volume: ~1.5 L/day (range 1-2 L)
• pH: 8.0-8.3 (alkaline)
• Appearance: Clear, watery
• The pancreas has the highest rate of protein synthesis and secretion of any organ in the body, delivering 15-100 g of protein into the small intestine daily.

II. COMPOSITION OF PANCREATIC JUICE

A. Aqueous (Inorganic) Component - Secreted by Ductal (Centroacinar) Cells

B. Enzymatic (Organic) Component - Secreted by Acinar Cells

1. Proteolytic Enzymes (Proteases) - secreted as INACTIVE ZYMOGENS

Enterokinase (Enteropeptidase) is the key enzyme on the duodenal brush border that cleaves trypsinogen → trypsin. Trypsin then activates all other zymogens (cascade activation). Why zymogens? To prevent autodigestion of the pancreas. Additional protection by Pancreatic Secretory Trypsin Inhibitor (PSTI) which blocks any prematurely activated trypsin within the acinar cell.

2. Amylolytic Enzyme - secreted as ACTIVE form

• α-Amylase: Cleaves internal α-1,4 glycosidic bonds of starch and glycogen → maltose, maltotriose, α-dextrins. Cannot cleave α-1,6 bonds (branch points).

3. Lipolytic Enzymes - secreted as ACTIVE or minimally active forms

4. Nucleolytic Enzymes - secreted as ACTIVE forms

• RNAase (Ribonuclease): Digests RNA
• DNAase (Deoxyribonuclease): Digests DNA

5. Other Proteins

III. FUNCTIONS OF PANCREATIC JUICE

1. Neutralization of Gastric Acid

• Highly alkaline HCO₃⁻ (pH ~8.1) neutralizes the acidic chyme entering the duodenum (pH ~2)
• Critical function: Creates an optimal pH environment (pH 6-7) for pancreatic enzyme activity - most pancreatic enzymes function best at neutral/slightly alkaline pH
• Protects duodenal mucosa from acid damage
• Facilitates micellar solubilization of lipids and optimal mucosal cell function

2. Protein Digestion

• Trypsin, chymotrypsin, elastase (endopeptidases) cleave internal peptide bonds → smaller polypeptides
• Carboxypeptidases A and B (exopeptidases) cleave from the C-terminus → amino acids
• Collective action produces short peptides and free amino acids ready for mucosal absorption

3. Carbohydrate Digestion

• α-Amylase converts starch → maltose, maltotriose, and limit dextrins
• These are further hydrolyzed by brush-border enzymes (maltase, isomaltase, sucrase)

4. Fat Digestion (most dependent on pancreatic function)

• Pancreatic lipase + colipase is the primary enzyme for triglyceride digestion → 2-monoglyceride + 2 fatty acids
• Phospholipase A₂ digests phospholipids
• Carboxyl ester lipase digests cholesterol esters and fat-soluble vitamins (A, D, E, K)
• Fat digestion has the smallest pancreatic reserve - steatorrhea appears first in pancreatic insufficiency (only when >90% of exocrine function is lost)

5. Nucleic Acid Digestion

• RNAase and DNAase break down nucleic acids from food

IV. CONTROL / REGULATION OF PANCREATIC SECRETION

A. Cephalic Phase

• Anticipation and ingestion of food triggers vagal (parasympathetic) efferents → acetylcholine acts on muscarinic (M3) receptors on acinar cells → enzyme-rich secretion
• 25% of maximal enzyme secretion
• Blocked by atropine (muscarinic antagonist) or vagotomy

B. Gastric Phase

• Distension of stomach → long vagovagal reflexes → modest enzyme secretion (10-20%)
• Gastrin has weak stimulatory effect via CCK1 receptors (structurally similar to CCK)

C. Intestinal Phase (Most Important - 50-80%)

1. Cholecystokinin (CCK) - "Enzyme Stimulator"

• Source: I cells of duodenal and jejunal mucosa
• Stimuli for release: Fatty acids (most potent, especially long-chain), amino acids (especially phenylalanine, valine, methionine), peptones in duodenum. Note: Carbohydrates and acid have little effect.
• Mechanism of CCK release: CCK-releasing factors (peptides from mucosal cells/pancreas) are normally degraded by basal pancreatic enzymes. After a meal, digestive enzymes are diverted to digest food → less degradation of CCK-releasing factors → more CCK release (a positive feedback loop that self-limits as digestion proceeds)
• Action: Stimulates acinar cells via CCK1 (CCKA) receptors → IP3/DAG pathway → ↑intracellular Ca²⁺ → exocytosis of zymogen granules → enzyme-rich secretion
• Also acts indirectly by activating vagal afferents → cholinergic stimulation of acinar cells
• CCK levels rise 5-10 fold within 10-30 minutes of a meal

2. Secretin - "Water and Bicarbonate Stimulator"

• Source: S cells of duodenal mucosa
• Stimuli for release: Duodenal acidification (pH must fall to <4.5) - the most potent stimulus. Also bile acids and lipids (to lesser extent)
• Action: Binds receptors on ductal (centroacinar) cells → adenylyl cyclase → ↑cAMP → PKA → activation of CFTR (Cl⁻ channel) and Cl⁻/HCO₃⁻ exchanger → large volume of watery, bicarbonate-rich secretion
• Secretin alone cannot fully account for the HCO₃⁻ response to a meal; it acts synergistically with CCK and ACh

D. Inhibition of Pancreatic Secretion

• Somatostatin: Released from D cells of pancreas and gut; inhibits both enzyme and bicarbonate secretion; reduces blood flow to pancreas
• Pancreatic polypeptide (PP): Released by F cells of islets during protein ingestion; acts via vagal pathways to inhibit enzyme and bicarbonate secretion
• Glucagon: Inhibits pancreatic secretion (anti-CCK effect)
• Fat in the distal small intestine: "Ileal brake" - fatty acids in the ileum inhibit upper GI motility and pancreatic secretion via PYY (peptide YY) and neurotensin → reduces further digestion

E. Interdigestive (Fasting) Secretion

• Basal, cyclic pattern corresponding to the Migrating Motor Complex (MMC) of the intestine
• Maximal during Phase III of MMC but only 10-20% of meal-stimulated rates
• Fluid/electrolyte secretion: <5% of maximum
• Regulated primarily by parasympathetic (cholinergic) tone and CCK; suppressed by α-adrenergic tone

V. PANCREATIC EXOCRINE FUNCTION TESTS

A. DIRECT (INVASIVE) TESTS - Stimulate the pancreas and collect juice

1. Secretin Stimulation Test (Gold Standard)

• Principle: Pancreatic secretory response is directly related to the functional mass of pancreatic tissue
• Method:
  1. Patient fasted overnight
  2. Fluoroscopic placement of double-lumen gastroduodenal tube (or upper endoscopy for ePFT)
  3. IV secretin injected: 0.2 μg/kg synthetic human secretin as bolus
  4. Duodenal juice collected over 60 minutes at intervals (15-min collections)
  5. Measure: Volume, bicarbonate concentration, enzyme output
• Normal Values:
  • Volume output: >2 mL/kg per hour
  • Peak bicarbonate concentration: >80 mmol/L
  • HCO₃⁻ output: >10 mmol/L in 1 hour
• Abnormal: Peak HCO₃⁻ <80 mmol/L = reduced ductal secretory function = suggests chronic pancreatitis (most reproducible parameter)
• Interpretation: Directly measures ductal epithelial function. An abnormal result indicates ductal dysfunction - this is an early abnormality in chronic pancreatitis, often preceding steatorrhea by years (because of the large reserve capacity for enzyme secretion)
• Limitation: Invasive; requires fluoroscopy or endoscopy; steatorrhea and secretin test results may dissociate (abnormal secretin but normal fat excretion in early disease)

2. Secretin-CCK (Lundh Test Equivalent / Combined Test)

• Combines secretin (for bicarbonate/volume) and CCK (for enzyme output)
• More complete assessment of both ductal and acinar function
• Normal enzyme response: amylase, lipase output above reference ranges

3. Endoscopic Pancreatic Function Test (ePFT)

• Principle: Same as secretin test but collection performed during upper endoscopy (avoids fluoroscopic tube placement)
• Secretin given IV → duodenal juice aspirated endoscopically
• Advantages: No need for fluoroscopy; high sensitivity for early chronic pancreatitis; high negative predictive value (normal ePFT essentially rules out significant chronic pancreatitis)
• Disadvantage: Requires sedation

4. EUS-ePFT (Combined Endosonography + Functional Test)

• Combines endoscopic ultrasound (EUS) evaluation of pancreatic parenchyma/ductal architecture with endoscopic collection of secretin-stimulated juice
• Single endoscopic procedure for both structure and function
• Most comprehensive evaluation for chronic pancreatitis

5. Secretin-Enhanced MRCP (sMRCP)

• Non-invasive; combines imaging of pancreatic ductal anatomy (MRCP) with semiquantitative estimation of juice output in duodenum after secretin
• Improved visualization of ductal anatomy
• Functional assessment less accurate than ePFT
• Preferred when invasive testing is not tolerated

B. INDIRECT (NON-INVASIVE) TESTS - Measure products of pancreatic digestion

1. Fecal Fat Estimation (van de Kamer Method) - Reference Standard for Fat Malabsorption

• Principle: Pancreatic lipase deficiency → impaired fat digestion → fat appears in stools (steatorrhea)
• Method: Patient on a fat-controlled diet (100 g fat/day) for 3 days, then 72-hour stool collection; fat content measured chemically
• Normal: <7 g fat/day in stool (or <7% of ingested fat)
• Abnormal: >7 g/day = steatorrhea (fat malabsorption)
• Limitation: Does not distinguish between pancreatic and non-pancreatic causes of malabsorption (e.g., mucosal disease, bile salt deficiency). Also, a qualitative assessment (Sudan stain of random stool sample) can be done but is less reliable.
• Important: Steatorrhea from pancreatic insufficiency does not appear until >90% of exocrine function is destroyed - this test detects only advanced disease

2. Fecal Elastase-1 (FE-1) Test - Most Widely Used Non-Invasive Test

• Principle: Pancreatic elastase is secreted in juice and is not degraded during intestinal transit → its concentration in stool reflects pancreatic secretory output
• Method: Single random stool sample; ELISA using human elastase-specific antibody (not degraded by intestinal bacteria)
• Normal: FE-1 >200 μg/g stool
• Mild-Moderate EPI: 100-200 μg/g
• Severe EPI: <100 μg/g
• Advantages: Simple, cheap, non-invasive, no dietary preparation, not affected by pancreatic enzyme replacement therapy (uses human-specific antibody)
• Limitations:
  • False positives (falsely low FE-1) with watery/unformed stools (dilution effect) - should not be used in patients with diarrhea
  • False positives also in: diabetes mellitus, irritable bowel syndrome, celiac disease
  • Sensitivity highest when pretest probability is high and value is <100 μg/g
  • Less sensitive for mild-moderate EPI

3. Serum Trypsinogen (Immunoreactive Trypsinogen - IRT)

• Normal serum trypsinogen: 10-57 ng/mL (by RIA)
• Low IRT (<20 ng/mL): Suggests chronic pancreatitis with significant parenchymal loss (advanced EPI)
• High IRT: Acute pancreatitis, renal failure, pancreatic cancer (early stages)
• Simple blood test; used as a screening marker

4. Serum/Urine Amylase and Lipase

• Elevated in acute pancreatitis (diagnostic)
• Low levels in advanced chronic pancreatitis (burnt-out pancreas)
• Serum amylase: Rises within 2-12 hours of acute pancreatitis, normalizes in 3-5 days
• Serum lipase: More specific for pancreatic disease; remains elevated longer (7-14 days)
• Amylase:Creatinine clearance ratio: Used if macroamylasemia suspected

5. Secretin-MRCP (already listed above as sMRCP)

6. NBT-PABA Test (N-Benzoyl-L-Tyrosyl-p-Aminobenzoic Acid / Bentiromide Test) - Older test

• Bentiromide (synthetic peptide) given orally → chymotrypsin cleaves it → releases PABA → absorbed → excreted in urine
• Measure urinary PABA: low excretion = reduced chymotrypsin = EPI
• Limitation: Affected by renal disease, small bowel mucosal disease; largely replaced by fecal elastase

7. Pancreolauryl Test

• Fluorescein dilaurate (ester) is given orally → pancreatic cholesterol esterase cleaves it → fluorescein absorbed → measured in urine or serum
• Reduced fluorescein = reduced esterase = EPI
• Simple, cheap; less used now due to fecal elastase availability

SUMMARY TABLE: Pancreatic Exocrine Function Tests

WBUHS Exam Tip: This is a classic 12-mark LAQ. Structure your answer with clear headings: Composition (with enzyme table), Functions, Control (3 phases + CCK vs Secretin in detail), and Tests. Draw a small diagram of the 3 phases of secretion. Always mention enterokinase, the zymogen safety mechanism, and the CCK/secretin distinction - these are high-yield points frequently tested.

Pancreatic Juice - Composition, Functions, Control of Secretion and Exocrine Function Tests

INTRODUCTION

• Volume: ~1.5 L/day
• pH: 8.0 - 8.3 (alkaline)
• Appearance: Clear, colourless, watery fluid

I. COMPOSITION OF PANCREATIC JUICE

A. Inorganic (Aqueous) Component - Secreted by Ductal Cells

B. Organic (Enzymatic) Component - Secreted by Acinar Cells

1. Proteolytic Enzymes - Secreted as INACTIVE ZYMOGENS

Why secreted as zymogens? To prevent autodigestion of the pancreas. Additional protection is provided by Pancreatic Secretory Trypsin Inhibitor (PSTI), which inactivates any trypsin prematurely activated within acinar cells.

Enterokinase (Enteropeptidase), present on the duodenal brush border, cleaves trypsinogen → trypsin. Trypsin then activates all other zymogens in a cascade.

2. Amylolytic Enzyme - Secreted in ACTIVE form

• α-Amylase: Cleaves internal α-1,4 glycosidic bonds of starch → maltose, maltotriose, and α-dextrins

3. Lipolytic Enzymes - Secreted in ACTIVE or minimally active forms

4. Nucleolytic Enzymes - Secreted in ACTIVE form

• RNAase - digests RNA
• DNAase - digests DNA

5. Other Proteins

• PSTI (Pancreatic Secretory Trypsin Inhibitor): Prevents premature trypsin activation inside acinar cells
• Lithostatine: Inhibits calcium carbonate precipitation; prevents stone formation in pancreatic ducts
• Pancreatitis-associated protein: Bacteriostatic agent; levels rise markedly during pancreatic injury

II. FUNCTIONS OF PANCREATIC JUICE

• Endopeptidases (trypsin, chymotrypsin, elastase) cleave internal peptide bonds → smaller polypeptides
• Exopeptidases (carboxypeptidases A and B) cleave from the C-terminal end → free amino acids
• Final products: short peptides and amino acids - ready for mucosal absorption

III. CONTROL OF PANCREATIC SECRETION

Diagram: Three Phases of Pancreatic Secretion

CEPHALIC PHASE          GASTRIC PHASE         INTESTINAL PHASE
(25% of max)            (10-20% of max)        (50-80% of max)
    |                        |                        |
Sight, smell,          Gastric distension       Fat, AA, H⁺
taste, chewing               |                  in duodenum
    |                  Vagovagal reflex               |
Vagal efferents              |               CCK (I cells) + Secretin
    |                  Acetylcholine              (S cells)
Acetylcholine                |                        |
    |                  Acinar cells           Acinar + Duct cells
Acinar cells                 |                        |
    |               Enzyme-rich secretion    Enzyme + HCO₃⁻ rich
Enzyme secretion                              secretion

A. Cephalic Phase (25% of maximal secretion)

• Stimuli: Sight, smell, taste, and chewing of food
• Mechanism: Stimuli activate cerebral cortex → hypothalamus → dorsal vagal nucleus → vagal (parasympathetic) efferents → acetylcholine acts on M3 muscarinic receptors on acinar cells → enzyme-rich secretion
• Blocked by atropine or vagotomy

B. Gastric Phase (10-20% of maximal secretion)

• Stimulus: Distension of stomach wall
• Mechanism: Long vagovagal reflexes (gastric distension → vagal afferents → vagal efferents → acinar cells) → enzyme secretion
• Gastrin has a weak stimulatory effect on acinar cells via CCK1 receptors (structural similarity to CCK)

C. Intestinal Phase (50-80% of maximal secretion) - Most Important

1. Cholecystokinin (CCK) - Stimulates Enzyme Secretion

2. Secretin - Stimulates HCO₃⁻ and Water Secretion

D. Inhibition of Pancreatic Secretion

• Somatostatin (from D cells): Inhibits both enzyme and bicarbonate secretion
• Pancreatic polypeptide (PP): Released by F cells of islets; inhibits enzyme and bicarbonate secretion via vagal pathways
• Glucagon: Inhibits pancreatic secretion
• Ileal brake: Fat in the distal ileum triggers PYY release → inhibits pancreatic secretion (reduces further output once food is in the ileum)

IV. TESTS OF EXOCRINE PANCREATIC FUNCTION

A. DIRECT TESTS (Invasive) - Stimulate pancreas, collect and measure juice

1. Secretin Stimulation Test (Gold Standard)

• Principle: The pancreatic secretory response is directly related to the functional mass of pancreatic tissue
• Method:
  1. Patient fasted overnight
  2. Gastroduodenal tube placed fluoroscopically in duodenum
  3. IV secretin 0.2 μg/kg given as bolus
  4. Duodenal juice collected over 60 minutes (at 15-min intervals)
  5. Measure: volume, bicarbonate concentration, HCO₃⁻ output

• Abnormal: Peak HCO₃⁻ <80 mmol/L = ductal secretory dysfunction = early chronic pancreatitis
• Most reproducible parameter: Maximal bicarbonate concentration
• Limitation: Invasive; steatorrhoea and secretin test results may dissociate (abnormal secretin test but normal fat excretion is common in early disease - because of large pancreatic enzyme reserve)

2. Endoscopic Pancreatic Function Test (ePFT)

• Secretin-stimulated collection of pancreatic juice performed during upper endoscopy
• Replaces need for fluoroscopic tube placement
• Advantages: High sensitivity for early chronic pancreatitis; high negative predictive value (normal ePFT effectively rules out chronic pancreatitis); well tolerated
• Disadvantage: Requires sedation

3. Secretin-Enhanced MRCP (sMRCP)

• Non-invasive
• Combines MRI imaging of pancreatic ductal anatomy with semiquantitative estimation of juice output in the duodenum after IV secretin
• Improved visualisation of ductal anatomy
• Functional assessment less accurate than ePFT
• Useful when invasive testing is not feasible

B. INDIRECT TESTS (Non-invasive) - Measure products of digestion or enzymes in stool/blood

1. Fecal Fat Estimation - Reference Standard for Fat Malabsorption

• Principle: Pancreatic lipase deficiency → impaired fat digestion → fat appears in stool (steatorrhoea)
• Method: Patient on 100 g fat/day diet for 3 days → 72-hour stool collection → fat measured chemically (van de Kamer method)
• Normal: <7 g fat/day
• Abnormal: >7 g/day = steatorrhoea = fat malabsorption

• Limitation: Does not distinguish between pancreatic and non-pancreatic causes (e.g., mucosal disease, bile salt deficiency). Steatorrhoea from pancreatic insufficiency appears only when >90% of exocrine function is lost - detects only advanced disease.

2. Fecal Elastase-1 Test (FE-1) - Most Widely Used Non-Invasive Test

• Principle: Pancreatic elastase-1 is secreted in juice and is not degraded during intestinal transit → its concentration in stool reflects pancreatic secretory output
• Method: Single random stool sample (formed stool) → ELISA using human elastase-specific antibody
• Interpretation:

• Advantages: Simple, non-invasive, cheap, single stool sample, not affected by pancreatic enzyme replacement therapy (uses human-specific antibody)
• Limitations:
  • False positive (falsely low FE-1) with watery/unformed stools due to dilution - do not use in patients with diarrhea
  • False positives also in: diabetes mellitus, irritable bowel syndrome, celiac disease
  • Lower sensitivity for mild-moderate EPI

3. Serum Amylase and Lipase

• Used mainly for acute pancreatitis diagnosis, not EPI

4. Serum Trypsinogen (Immunoreactive Trypsinogen - IRT)

• Normal: 10-57 ng/mL
• Low IRT (<20 ng/mL): Advanced chronic pancreatitis with significant parenchymal loss
• High IRT: Acute pancreatitis, early pancreatic cancer
• Simple blood test; used as a screening marker for EPI

5. NBT-PABA Test (Bentiromide Test) - Older, less used

• Bentiromide (synthetic peptide) is given orally → chymotrypsin cleaves it → releases PABA → PABA absorbed → excreted in urine
• Low urinary PABA = reduced chymotrypsin = EPI
• Largely replaced by fecal elastase test

Summary Table: Tests at a Glance

CLINICAL IMPORTANCE

1. In chronic pancreatitis, the secretin test detects ductal dysfunction early - often before steatorrhoea develops (because of large pancreatic enzyme reserves)
2. Steatorrhoea does not appear until >90% of the exocrine pancreas is destroyed - indicating that only small amounts of lipase are needed for adequate fat digestion
3. Pancreatic enzyme deficiency affects fat digestion first (least reserve), followed by protein, then carbohydrate digestion (most reserve)
4. The fecal elastase-1 test is the most practical first-line non-invasive test in clinical and outpatient settings

Important: What You Likely Have is NOT a Common Cold

Please see an ENT (Ear, Nose, Throat) doctor for a proper diagnosis before continuing any medicine. 2-3 months of symptoms requires examination and possibly an X-ray or nasal endoscopy.

Your Current Medicines - Assessment

1. Divya Tablets (Patanjali)

2. Swasthi Gold Tablet (Patanjali)

Better Patanjali / Ayurvedic Medicines for Your Condition

For Nose Block and Sinus Congestion:

• Best for thick sputum, nose congestion, heaviness
• Contains: Vanshlochan (bamboo silica), Pippali (long pepper), Cardamom, Dalchini
• Dose: 3-5 g with honey, twice daily after meals
• This is specifically targeted at your symptoms

• Medicated herbal oil for nasal instillation (Nasya therapy in Ayurveda)
• Put 2-3 drops in each nostril in the morning while lying down with head tilted back
• Clears nasal passages, lubricates the mucosa, reduces chronic congestion
• This is the single most effective Ayurvedic treatment for chronic nose block
• Available at Patanjali stores

• Specifically for sinusitis and upper respiratory congestion
• Boil 5-10 g in 400 mL water, reduce to 100 mL, drink twice daily
• Reduces inflammation of nasal and sinus lining

• Contains Ginger, Black Pepper, Pippali
• Helps digest mucus (Kapha) and clear airways
• Dose: 1-2 g with warm water or honey, once daily

• Contains menthol, camphor, eucalyptus oil
• Apply under the nostrils or inhale from bottle for immediate relief of block
• Quick relief; use 2-3 times a day

Steam Inhalation - Most Effective Home Remedy

• Boil water, add a few drops of Nilgiri oil (Eucalyptus oil) or a teaspoon of Ajwain (Carom seeds)
• Inhale steam for 10-15 minutes, twice daily (morning + evening)
• This loosens sputum, opens blocked passages, and reduces inflammation

Lifestyle Advice (Important for Permanent Relief)

1. Jal Neti (Saline Nasal Rinse): Use a Neti pot with lukewarm saline water (1/4 tsp salt in 500 mL warm water) to flush the nasal passages daily. This is the most powerful Ayurvedic remedy for chronic sinusitis - Baba Ramdev himself recommends it strongly.
2. Avoid cold drinks, ice cream, and cold water - these aggravate Kapha (mucus)
3. Avoid dust, smoke, and cold air exposure - if these trigger your symptoms, allergic rhinitis is likely
4. Pranayama (breathing exercises): Kapalbhati (10-15 minutes daily) and Anulom Vilom - these strengthen the respiratory system and reduce chronic mucus buildup over weeks of regular practice
5. Drink warm water throughout the day - helps thin and drain mucus
6. Turmeric milk (Haldi Doodh) - 1 tsp turmeric in warm milk at bedtime - anti-inflammatory, helps reduce sinus congestion

Suggested Daily Routine

When to See a Doctor - Warning Signs

• Symptoms persisting beyond 3 months despite treatment
• Pain or pressure in face/forehead/around eyes
• Fever
• Loss of smell
• Blood in nasal discharge
• Headache that is worsening

Sitopaladi Churna - Complete Composition

Ingredients (Classical Ratio as per Sharangdhara Samhita)

The ratio is 16 : 8 : 4 : 2 : 2 - each ingredient is exactly half the previous one. This is easy to remember.

Role of Each Ingredient

1. Sitopala (Rock Sugar) - 16 parts

• The largest component - gives the churna its sweet taste
• Acts as a base and vehicle (anupana)
• Has cooling, soothing properties on the throat and respiratory mucosa
• Reduces burning sensation; mild expectorant
• Balances Pitta (heat/inflammation)
• "Sitopala" literally means "cool/sweet crystal" - the churna is named after this ingredient

2. Vanshlochan (Bamboo Silica) - 8 parts

• The white chalky substance found naturally inside bamboo internodes
• Rich in silica, calcium, and flavonoids
• Key action: Expectorant - helps loosen and expel thick mucus/sputum
• Strengthens lung tissue; anti-inflammatory
• Balances Kapha (mucus/congestion)
• This is the primary ingredient for sputum and nose congestion

3. Pippali (Long Pepper) - 4 parts

• Bioactive compound: Piperine (also found in black pepper but more concentrated in long pepper)
• Key action: Deepan (digestive stimulant) + Kapha-nashak (mucus destroyer)
• Breaks down and liquefies thick mucus, making it easier to expel
• Stimulates respiratory tract, opens airways
• Enhances bioavailability of other ingredients (similar to how piperine enhances curcumin absorption)
• Mild bronchodilator effect
• Also a rasayana (rejuvenative) for the lungs

4. Ela / Cardamom (seeds only) - 2 parts

• Contains cineole (eucalyptol) - the same compound in eucalyptus
• Key action: Opens airways, relieves congestion, anti-spasmodic
• Freshens breath, soothes throat irritation
• Carminative - prevents nausea or gastric upset from the other ingredients
• Mild antimicrobial properties

5. Twak / Cinnamon bark - 2 parts

• Contains cinnamaldehyde and eugenol
• Key action: Anti-microbial, anti-inflammatory, warming
• Helps fight respiratory infections
• Stimulates circulation to the respiratory tract
• Balances Vata and Kapha
• Aids digestion and absorption of the churna

How It Works Together (Ayurvedic View)

• Rock sugar + Cardamom → soothe and cool irritated airways
• Vanshlochan + Pippali → break down and expel mucus
• Cinnamon → fight infection and warm the channels
• Together: Reduces cough, clears sputum, opens blocked nose, improves breathing

Dose and How to Take

With honey is the best way to take it for nose block and sputum - honey itself is an excellent mucolytic (mucus-loosening agent) in Ayurveda.

What It Treats

• Chronic cough (dry or wet)
• Nose block and nasal congestion
• Thick sputum / phlegm
• Sinusitis
• Bronchitis
• Loss of appetite (due to Pippali)
• Mild fever associated with respiratory infections
• Chest heaviness

Safety and Cautions

Giloy (Tinospora cordifolia / Guduchi) - Effects on the Human Body

Active Chemical Compounds

Effects on Each System of the Body

1. IMMUNE SYSTEM - Most Well-Known Effect

• Activates macrophages (white blood cells that engulf pathogens) - increases their phagocytic activity
• Stimulates production of cytokines (immune signalling molecules) - IL-1, IL-6, TNF-α
• Increases T-lymphocyte and B-lymphocyte activity
• Stimulates production of antibodies
• Polysaccharides (arabinogalactan) directly activate the complement system

• Giloy extract significantly reduces severity and duration of recurrent fever and infections
• Shown to improve immune response in dengue fever patients (increases platelet count)
• Used during COVID-19 pandemic in India as an immune support herb

2. RESPIRATORY SYSTEM

• Reduces inflammation of the nasal and bronchial mucosa
• Antihistamine effect: Reduces allergic response - useful in allergic rhinitis
• Reduces IgE levels (the antibody responsible for allergies)
• In one clinical study, Giloy significantly reduced symptoms of allergic rhinitis - sneezing, nasal discharge, nasal block, and itching - compared to placebo
• Mild bronchodilator effect - helps in asthma

This makes Giloy particularly useful for your chronic nose block problem - especially if it has an allergic component.

3. ANTI-FEVER (Antipyretic) Effect

• One of its oldest uses - "Jwaranashini" (fever destroyer) in Ayurveda
• Tinospora alkaloids reduce fever by acting on the hypothalamic thermoregulatory centre
• Effective in dengue fever, malaria, typhoid, and general viral fevers
• In dengue: Giloy juice is widely used to boost platelet count (thrombocytopenia)
• Mechanism: Inhibits prostaglandin synthesis (similar to paracetamol mechanism)

4. BLOOD SUGAR (Anti-Diabetic) Effect

• One of the better-studied effects with clinical evidence
• How it works:
  • Stimulates insulin secretion from pancreatic beta cells
  • Increases peripheral glucose uptake by cells
  • Inhibits gluconeogenesis (liver's production of new glucose)
  • Reduces intestinal absorption of glucose
• Clinical studies show: Fasting blood glucose reduced by 15-25% with regular Giloy use in Type 2 diabetics
• Caution: Can lower blood sugar too much if combined with diabetes medicines - dose adjustment needed

5. LIVER (Hepatoprotective) Effect

• Protects liver cells from toxin-induced damage
• Useful in jaundice, hepatitis, and alcoholic liver disease
• Increases liver enzyme levels (ALT, AST) return to normal faster
• Mechanism: Strong antioxidant activity in liver cells; reduces lipid peroxidation
• Promotes bile production and improves fat digestion

6. ANTI-INFLAMMATORY AND ANTI-ARTHRITIC EFFECT

• Berberine and other alkaloids inhibit COX-2 enzyme (same target as ibuprofen)
• Reduces production of inflammatory prostaglandins
• Clinical studies in Rheumatoid Arthritis: Reduced joint pain, swelling, and morning stiffness
• Useful in gout - reduces uric acid levels
• Anti-arthritic effect is well-recognised even in modern pharmacology

7. DIGESTIVE SYSTEM

• Digestive stimulant (Deepan): Stimulates gastric acid and digestive enzyme secretion
• Reduces hyperacidity and peptic ulcers (protects stomach lining)
• Relieves constipation - mild laxative at higher doses
• Reduces nausea and vomiting
• Anti-dysenteric: Berberine is active against intestinal infections (E. coli, Shigella, Salmonella)

8. NERVOUS SYSTEM (Adaptogenic / Anti-Stress Effect)

• Classified as an Adaptogen - helps the body cope with physical and mental stress
• Reduces cortisol levels (stress hormone) - similar to Ashwagandha
• Mild anxiolytic (anti-anxiety) effect in animal studies
• Improves cognitive function and memory - used in Ayurveda for brain health
• Reduces fatigue and body heaviness (which you are experiencing - the "leginess/heaviness" you described)
• Traditional use in medhya rasayana (brain tonic) formulations

9. ANTI-OXIDANT EFFECT

• Scavenges free radicals throughout the body
• Reduces oxidative stress - one of the underlying causes of chronic diseases
• Protects DNA from oxidative damage
• Increases activity of body's own antioxidant enzymes: SOD (superoxide dismutase), catalase, glutathione

10. ANTI-MICROBIAL EFFECT

• Active against bacteria: Staphylococcus aureus, E. coli, Salmonella typhi, Klebsiella
• Anti-fungal activity
• Anti-malarial: Berberine has demonstrated activity against Plasmodium falciparum
• Anti-viral: Shown to inhibit replication of various viruses including influenza

11. ANTI-CANCER (Preliminary Evidence)

• Note: This is lab/animal evidence only - not proven in human clinical trials yet
• Extracts shown to induce apoptosis (programmed death) in cancer cell lines
• Anti-proliferative effect against breast, lung, liver cancer cells in lab studies
• Antioxidant effect may reduce cancer risk long-term
• Should NOT be used as a cancer treatment - only supportive role

12. SKIN

• Anti-inflammatory and antioxidant effects help in skin diseases (eczema, psoriasis)
• Giloy lotion/topical application studied for scabies treatment (mentioned in dermatology literature)
• Improves skin texture and reduces aging signs (antioxidant)

Forms Available and How to Use

Side Effects and Cautions

Important note on liver safety: There were reports of liver damage linked to Giloy products in 2021-2022 in India. Investigations suggested contamination or use of wrong species. Use only reputed brands (Patanjali, Himalaya, Dabur) and do not exceed recommended doses.

Summary: What Giloy Does for YOUR Condition

• Boosts your immune system to fight the ongoing infection ✓
• Reduces allergic inflammation in nasal mucosa ✓
• Anti-fever and anti-viral effect ✓
• Reduces body heaviness and fatigue (adaptogenic effect) ✓
• Anti-inflammatory - reduces swelling of nasal lining ✓